Another medical Cannabis dispensary opens in Hawaii on Oahu Island.
According to KITV news, a blessing was held earlier today at 10:30 a.m.
“The 24-hundred square food facility will offer locally grown medical-grade cannabis products to customers with 329 cards. The company says the Department of Health will conduct a final inspection this week then an official opening date will be determined for later this month.”
According to the Star Advertiser,
“The dispensary at 727 Kapahulu Ave. is one of three on Oahu, which already has Aloha Green Apothecary and Noa Botanicals in Honolulu.”
“Cure Oahu, backed by a local private investment group, will sell indica, sativa and hybrid cannabis flower strains, as well as lozenges and tinctures, when it opens to patients as early as next week.”
“Green Aloha on Kauai said on its website it is scheduled to open this month by appointment only.
Two others, on Hawaii island, are projected to open by the summer, according to the Health Department. There were 20,518 medical pot card holders as of Feb. 28.”
Big Island Now quoted keith Ridley,
“Ensuring patient safety through product safety is our top priority,” who oversees DOH’s medical cannabis dispensary program and serves as chief of the Office of Health Care Assurance.
“We continue to work collaboratively with the licensed dispensaries and private laboratories to help them meet the legal requirements efficiently while keeping patient safety top-of-mind.”
According to bizjournals.com,
“Cure Oahu is the first dispensary to open in 2018. Hawaiian Ethos LLC and Lau Ola LLC on the Big Island and Green Aloha, Ltd. on Kauai are still awaiting approval to being sales. Maui Grown Therapies, Aloha Green Apothecary, Pono Life Sciences Maui LLC and Noa Botanicals, all opened between August and October of last year.”
Many seem to think the Aloha State would do well to work with patients and doctors to create a medical Cannabis program for patients who rely on Cannabis.
“Any drug policy should first and foremost seek to reduce harm, and pain, not increase it. As someone interested in evidence-based policy, I feel the case for medical cannabis is overwhelming.”
—Richard Branson, business magnate and member of the Global Commission on Drug Policy, in a Virgin.com editorial